Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma-Reference-Cited by-同舟云学术

Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma

Published:2011-04-01 Issue:4 Volume:121 Page:1313-1328
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Cascone Tina,Herynk Matthew H.,Xu Li,Du Zhiqiang,Kadara Humam,Nilsson Monique B.,Oborn Carol J.,Park Yun-Yong,Erez Baruch,Jacoby Jörg J.,Lee Ju-Seog,Lin Heather Y.,Ciardiello Fortunato,Herbst Roy S.,Langley Robert R.,Heymach John V.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference80 articles.

1. Angiogenesis.

2. Tumor Angiogenesis: Therapeutic Implications

3. Angiogenesis in cancer and other diseases

4. The biology of VEGF and its receptors

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new perspective on antiangiogenic antibody drug resistance: Biomarkers, mechanisms, and strategies in malignancies;Drug Development Research;2024-09

2. Exploring treatment options in cancer: tumor treatment strategies;Signal Transduction and Targeted Therapy;2024-07-17

3. Effects of neratinib on angiogenesis and the early stage of the embryo using chicken embryo as a model;Biomolecules and Biomedicine;2023-12-27

4. Targeting vascular normalization: a promising strategy to improve immune–vascular crosstalk in cancer immunotherapy;Frontiers in Immunology;2023-12-15

5. ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy;Nature Metabolism;2023-09-04